CCL2 and type 2 diabetes mellitus: The results of this experiment showed that in the T2DM mice, insulin resistance could delay the progression of T2DM by promoting the expression of TNF-α and MCP-1 inflammatory factors, while KRS treatment significantly inhibited the upregulation of inflammatory factors.